Future Science Group

In this latest edition of NCTalks, Sharon Salt (Editor) speaks with Jens Kuhle, a neurologist at the University Hospital Basel, Switzerland. Jens is the head of the multiple sclerosis (MS) center at the hospital and runs a research group called ‘Translational Biomarkers and Biobanking’. In this podcast, Jens speaks about monitoring MS using blood neurofilament light protein and how this could impact the way we monitor and treat MS. Jens also discusses how he overcame the hurdle of measuring neurofilament in the blood and what the next steps are for his team.

In this latest edition of NCTalks, Lauren Pulling (Publisher) speaks to Giovanni Baranello, a Pediatric Neurologist working at the Carlo Besta Neurological Institute (Milan, Italy). Giovanni is the principal investigator of the FIREFISH clinical trial, a preliminary study investigating the safety and efficacy of RO7034067 in infants with type 1 spinal muscular atrophy. In this podcast recorded at the American Academy of Neurology’s 70th Annual Meeting (April 21–27, CA, USA), Giovanni speaks about the FIREFISH trial and the mechanisms of RO7034067. Giovanni also discusses part II of the study and what the next steps include, and where the field could be in 5–10 years’ time. View more podcasts, news and exclusive interviews at www.neuro-central.com

As part of our Spotlight, we present this interview with Cory Muraco who discusses his interest in chromatography, the technologies he uses and his top three tips for chromatographic method development.

As part of our focus, In the Zone: old vs new technologies, we present this podcast where we talk to Franklin Spriggs (Director of Large Molecule Services, KCAS) about his experience with investing in different technologies, and the key questions that need to be addressed when making any decision between different technologies. To find out more, visit: http://bit.ly/2rwG1fZ

Last week we had the pleasure of attending the American Academy of Neurology’s 70th Annual Meeting (April 21–27, CA, USA), where we spoke to Robert Fox, from the Mellen Center for Multiple Sclerosis at the Cleveland Clinic (OH, USA), about the Phase II SPRINT-MS trial of ibudilast in progressive multiple sclerosis. In this #NCTalks podcast recorded at the event, Lauren Pulling (Publisher) speaks to Robert, who is the Protocol Principal Investigator in the trial, to learn more about the current landscape that led to this research and potential treatment regimens. Listen to our podcast below to find out more. View more podcasts, news and exclusive interviews at www.neuro-central.com

Whilst at the Alzheimer’s Research UK (ARUK) Conference (20–21 March, London, UK), Lauren Pulling (Publisher) spoke to Giovanna Malluci, a Professor of Clinical Neurosciences at the University of Cambridge (UK) and Consultant Neurologist specializing in dementia. Giovanna is also the Associate Director of the Cambridge Center of the UK Dementia Research Institute (DRI). In this #NCTalks podcast recorded at the ARUK Conference, Giovanna speaks about translating innovation from lab to clinic across the UK DRI, promising dementia research themes and what the dementia research landscape could look like in 10 years' time. View more podcasts, news and exclusive interviews at www.neuro-central.com

In this podcast, Eppendorf Bioprocess Field Application Specialist Ankita Desai discusses the challenges of scaling up a cell therapy.

This week we had the pleasure of attending the American Academy of Neurology’s 70th Annual Meeting (April 21–27, CA, USA), where we spoke to Alexander Rae-Grant, from the Cleveland Clinic Lerner Medical School (OH, USA), about the new guideline for multiple sclerosis treatment. Alexander is the lead author of the multiple sclerosis guideline for the American Academy of Neurology. In this #NCTalks podcast recorded at the event, Lauren Pulling (Senior Editor) speaks to Alexander to learn more about the new guideline, how it compares to the last guideline and how it will affect the treatment practice for multiple sclerosis. View more podcasts, news and exclusive interviews at www.neuro-central.com

In this latest edition of NCTalks, Lauren Pulling (Editor) chats with Tara Spires-Jones, a Professor of Neurodegeneration at the University of Edinburgh (UK). Tara is Deputy Director of the Centre for Discovery Brain Sciences and Program Lead at the Edinburgh center of the UK Dementia Research Institute. Tara is also Chair of the Alzheimer’s Research UK (ARUK) Grant Review Board, and is active is science communications and outreach – making her a very busy person! In this podcast recorded at the ARUK Conference in London (21–22 March 2018), Tara shares her recent research into the roles of ApoE4 and clusterin in synapse degeneration in Alzheimer’s disease and the viability of synapse degeneration as a treatment target. Tara also discusses animal models of neurodegeneration, the impact of cuts to neuroscience funding, and the importance of mentorship in science. View more podcasts, news and exclusive interviews at www.neuro-central.com

The Microbe Directory is a collective research effort aiming to profile over 7,000 microbes in order to provide further information for any researchers carrying out metagenomic analyses. We spoke to two of the Project Leaders, Heba Shaaban and David Westfall about the project, how it’s being used in research and how you can get involved.

Listen to the top stories in infectious diseases this week, including novel CRISPR-based diagnostics, clinical trial in tuberculosis and the latest CDC approvals for the flu vaccine. Find the full stories: https://www.id-hub.com

Take a look at the top news stories of the week, including the measles vaccine and the sexual transmission of Zika.

In the final part of this 3-part panel discussion, our experts talk through the recent changes in the type of molecules and technologies the field are working with and what new technologies need to emerge to overcome current problems.

In part 2 of this 3-part panel discussion our panelists discuss the exciting topic of regulations as they consider the ICH M10 guidance and where they think the field might be going in the future.

In part 1 of this 3-part panel discussion highlight filmed in Barcelona our panel of experts discuss the issue of outsourcing and what priorities are need considering when making a purchasing

As part of our focus, we present this podcast where Dr Dominic Warrino discusses how immuno-oncology fits into the bioanalytical field and the technologies involved.

In this interview Roshaine Wijayatunga (Senior Editor: Oncology) speaks with David Jayne about colorectal surgery in regards to the development, application and evaluation of new surgical technologies.

In this interview Roshaine Wijayatunga (Senior Editor: Oncology) speaks with Matthew Ellis at the 2017 NCRI Cancer Conference 5–8 Nov 2017 about the future of proteomics and breast cancer research.

In this interview Roshaine Wijayatunga (Senior Editor: Oncology) speaks with Michael Douek at the 2017 NCRI Cancer Conference 5–8 Nov 2017 about novel techniques for breast surgery and reconstruction.

In this World AIDS Day interview we speak to Richard Koup, who was recently an author on a study reporting a trispecific antibody able to target 99% of HIV strains. www.id-hub.com